Fox Run Management L.L.C. Takes $482,000 Position in Option Care Health, Inc. (NASDAQ:OPCH)

Fox Run Management L.L.C. purchased a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 20,761 shares of the company’s stock, valued at approximately $482,000.

Other institutional investors have also added to or reduced their stakes in the company. Cornerstone Investment Partners LLC lifted its position in shares of Option Care Health by 3.6% during the 4th quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company’s stock worth $221,000 after buying an additional 333 shares in the last quarter. UMB Bank n.a. lifted its holdings in Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after acquiring an additional 346 shares during the period. Assetmark Inc. boosted its position in Option Care Health by 2.0% in the fourth quarter. Assetmark Inc. now owns 24,976 shares of the company’s stock worth $579,000 after purchasing an additional 487 shares during the last quarter. Pacer Advisors Inc. boosted its position in Option Care Health by 2.2% in the fourth quarter. Pacer Advisors Inc. now owns 25,483 shares of the company’s stock worth $591,000 after purchasing an additional 537 shares during the last quarter. Finally, Sheets Smith Wealth Management grew its stake in Option Care Health by 2.4% in the 4th quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company’s stock valued at $553,000 after purchasing an additional 550 shares during the period. 98.05% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares of the company’s stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Price Performance

OPCH stock opened at $35.18 on Wednesday. The firm has a 50 day moving average of $32.11 and a 200-day moving average of $28.33. The firm has a market capitalization of $5.78 billion, a P/E ratio of 29.56, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.44. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Wall Street Analyst Weigh In

OPCH has been the topic of a number of recent analyst reports. UBS Group started coverage on Option Care Health in a research note on Thursday, December 5th. They set a “neutral” rating and a $26.00 target price on the stock. JMP Securities reiterated a “market outperform” rating and issued a $30.00 target price (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and increased their target price for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Barrington Research lifted their price target on shares of Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a report on Thursday, February 27th. Finally, Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $33.00.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.